Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs levonorgestrel intrauterine system
Menstrual blood loss PBAC score · heavy menstrual bleeding
1 finding from 1 review
- no estimate extracted1 study · 42 participantsVery low
Findings
What do systematic reviews say?
4 questions · 4 findings · 1 reviews · Gynaecology and Fertility
No studies found 1 · 25%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs levonorgestrel intrauterine system
Menstrual blood loss: improvement in mean blood loss (PBAC score < 100) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement in mean blood loss (PBAC score <… compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
- RR 0.43 [0.24, 0.77]1 study · 42 participantsVery low
Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs levonorgestrel intrauterine system
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
- RR 0.83 [0.25, 2.8]1 study · 42 participantsVery low
Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs levonorgestrel intrauterine system
Thromboembolic events · heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found